GeneDx (WGS) said Monday it expects fiscal Q4 revenue of $121 million.

Analysts polled by FactSet expect $120.4 million.

For full year 2025, the company said it expects total revenue of $427 million.

Analysts surveyed by FactSet expect $427 million.

The company also said it expects 2026 revenue of between $540 million and $555 million.

Analysts polled by FactSet expect $529.2 million.

GeneDx said it will report its Q4 results on Feb. 23 before the US market opens.

Shares of the company were down 8.4% in recent Monday premarket activity.